Literature DB >> 25534477

Successful treatment of Paecilomyces variotii peritonitis in a liver transplant patient.

Meltem Polat1, Soner Sertan Kara, Anıl Tapısız, Zeliha Demirtaş, Sinan Sarı, Ayşe Kalkancı, Hasan Tezer, Buket Dalgıç.   

Abstract

Paecilomyces variotii has previously been reported as a causative pathogen for peritonitis in patients on continuous ambulatory peritoneal dialysis and shown to be usually sensitive to amphotericin B and resistant to voriconazole. We report the first case, to our knowledge, of P. variotii peritonitis in a liver transplant patient, which was unresponsive to initial liposomal amphotericin B (L-AmB) treatment and resolved dramatically after the addition of voriconazole. The present case provides evidence for the clinical and microbiological effectiveness of voriconazole combined with L-AmB in treating P. variotii peritonitis refractory to initial L-AmB treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25534477     DOI: 10.1007/s11046-014-9854-1

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  13 in total

1.  Incidence and outcome of early Candida peritonitis after liver and pancreas transplantation.

Authors:  Michele Bartoletti; Carlos Cervera; Irma Hoyo; Laura Linares; Gemma Sanclemente; Jordi Bosch; Francesc Marco; Federico Cofán; María José Ricart; Miquel Navasa; Asunción Moreno
Journal:  Mycoses       Date:  2012-08-17       Impact factor: 4.377

2.  Voriconazole-resistant disseminated Paecilomyces variotii infection in a neutropenic patient with leukaemia on voriconazole prophylaxis.

Authors:  Georgios Chamilos; Dimitrios P Kontoyiannis
Journal:  J Infect       Date:  2005-11       Impact factor: 6.072

Review 3.  Paecilomyces peritonitis: case report and review of the literature.

Authors:  K Wright; S Popli; V C Gandhi; J R Lentino; C V Reyes; D J Leehey
Journal:  Clin Nephrol       Date:  2003-04       Impact factor: 0.975

4.  Efficacy of Amphotericin B at Suboptimal Dose Combined with Voriconazole in a Murine Model of Aspergillus fumigatus Infection with Poor In Vivo Response to the Azole.

Authors:  Marcelo Sandoval-Denis; F Javier Pastor; Javier Capilla; Josep Guarro
Journal:  Antimicrob Agents Chemother       Date:  2013-06-24       Impact factor: 5.191

5.  Peritonitis after liver transplantation: Incidence, risk factors, microbiology profiles, and outcome.

Authors:  Surakit Pungpapong; Salvador Alvarez; Walter C Hellinger; David J Kramer; Darrin L Willingham; Julio C Mendez; Justin H Nguyen; Winston R Hewitt; Jaime Aranda-Michel; Denise M Harnois; Barry G Rosser; Christopher B Hughes; Hani P Grewal; Raj Satyanarayana; Rolland C Dickson; Jeffrey L Steers; Andrew P Keaveny
Journal:  Liver Transpl       Date:  2006-08       Impact factor: 5.799

6.  Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: clearance with voriconazole.

Authors:  Charalampos Antachopoulos; Eugenia Papakonstantinou; John Dotis; Evangelia Bibashi; Maria Tamiolaki; Dimitrios Koliouskas; Emmanuel Roilides
Journal:  J Pediatr Hematol Oncol       Date:  2005-05       Impact factor: 1.289

Review 7.  Fungal peritonitis in peritoneal dialysis patients.

Authors:  Narayan Prasad; Amit Gupta
Journal:  Perit Dial Int       Date:  2005 May-Jun       Impact factor: 1.756

8.  Successful treatment of Trichosporon fungemia in a patient with refractory acute myeloid leukemia using voriconazole combined with liposomal amphotericin B.

Authors:  K Hosokawa; H Yamazaki; K Mochizuki; K Ohata; K Ishiyama; T Hayashi; Y Kondo; N Sugimori; H Okumura; A Takami; S Nakao
Journal:  Transpl Infect Dis       Date:  2011-09-28       Impact factor: 2.228

9.  Paecilomyces lilacinus peritonitis complicating peritoneal dialysis cured by oral voriconazole and terbinafine combination therapy.

Authors:  Brian Pin-Hsuan Chang; Pei-Lun Sun; Fu-Yuan Huang; Tsuen-Chiuan Tsai; Chun-Chen Lin; Ming-Dar Lee; Yee-Chun Chen; Jin-Cherng Sheu; Jeng-Daw Tsai
Journal:  J Med Microbiol       Date:  2008-12       Impact factor: 2.472

10.  Antifungal susceptibilities of Paecilomyces species.

Authors:  C Aguilar; I Pujol; J Sala; J Guarro
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

View more
  4 in total

1.  Paecilomyces variotii Fungemia in a Patient with Lymphoma Needing Liver Transplant.

Authors:  A P Bellanger; J P Cervoni; J F Faucher; D Weil-Verhoeven; M Ginet; E Deconinck; F Grenouillet
Journal:  Mycopathologia       Date:  2017-04-01       Impact factor: 2.574

2.  Disseminated Intravascular Infection Caused by Paecilomyces variotii: Case Report and Review of the Literature.

Authors:  Jacob E Lazarus; John A Branda; Ronak G Gandhi; Miriam B Barshak; Kimon C Zachary; Amy K Barczak
Journal:  Open Forum Infect Dis       Date:  2020-05-15       Impact factor: 3.835

Review 3.  Human Pathogenic Paecilomyces from Food.

Authors:  Danielly C Moreira; Manoel M E Oliveira; Cintia M Borba
Journal:  Microorganisms       Date:  2018-07-05

4.  Paecilomyces/Purpureocillium Infection in Children, Case Report, and Review of the Literature.

Authors:  Musaed Alharbi; Nourah Alruqaie; Ahmed Alzahrani; Maha Almuneef
Journal:  J Fungi (Basel)       Date:  2022-09-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.